Cardiovascular outcomes of antidiabetic drugs

Cardiovascular outcomes of antidiabetic drugs

Type 2 Diabetes Mellitus (T2DM) is associated with a high risk of atherosclerotic cardiovascular disease (ASCVD). Intensive blood glucose reduction with antidiabetic drugs significantly reduce microvascular complications but there is no strong evidence of reduction in cardiovascular (CV) events. In...

Full description

Bibliographic Details
Main Authors: Ranjit Kumar Nath, Neeraj Pandit, Ajay Raj, B.N Pandit, Vinod Kumar, Rajeev Bhardwaj, Ajay Pratap Singh, Ashok Thakur
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2021-03-01
Series:Asian Journal of Medical Sciences
Subjects:
antidiabetic drugs
cardiovascular outcomes
dpp 4 inhibitors
sglt2 inhibitors
glp-1 receptor agonist
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/32477

Internet

https://www.nepjol.info/index.php/AJMS/article/view/32477

Similar Items